ST27
ActiveSummary
ST27 has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.4m and a net result of €559,552. Equity has been growing by about 3.4% per year since 2018. Its solvency ranks better than 39% of 783 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 29-05-2009 Normal situation
- Registered office
- 579 active companies are registered at this address 51 started in the 12 months before. Source: KBO register, as of 5 November 2026.
- Activity
- Specialist medical practice NACE 86220
- Establishment unit
- 2.248.501.570 7522 Tournai, since 31-12-2015
- Financial year end
- 31 December
- Peppol
- Reachable since 05-09-2025
Board and ownership
- TOURBACH Sébastien André Gabriel JosephDirector · since 03-07-2023
- VERSYCK Maaike Irma ClaraDirector · since 03-07-2023
- Marieke VERSYCK50%annual accounts 2016
- Sébastien TOURBACH50%annual accounts 2016
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €1.2m
- ▼ 3.4%
- Turnover
- ≈ €1.1m
- estimated
- Profit
- €559,552
- ▼ 7.7%
- Equity
- €2.4m
- ▲ 2.6%
- Total assets
- €5.2m
- ▼ 2.2%
- Employees on 31-12-2025
- 2
- =
Score breakdownraises risk1 change of registered office in 24 monthslowers riskSize: 2 FTE, total assets €5.2mSector: Human health activities (NACE 86)Figures for financial year 2025 (filed on 05-06-2026)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 36% of them on solvency, 31% on liquidity, 30% on profitability and 43% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 36 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Registered office moved within IxellesNew registered office: Avenue Louise 231 1050 Ixelles · Previous registered office: Avenue Louise 523 à 1050 Ixelles
- · Gazette deed Changes of role: TOURBACH Sébastien André Gabriel Joseph (director) and VERSYCK Maaike Irma Clara (director)“La société a pour objet l’exercice, en son nom et pour son compte, de la médecine esthétique, la chirurgie…” (deed in French) · Legal-form conversion: from private limited company (pre-2019) to private limited company · Director discharge: TOURBACH Sébastien André Gabriel Joseph (manager)
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as ST27: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €3.4m and €6.5m, founded between 2004 and 2013.
| Company | Total assets | Gross margin |
|---|---|---|
| ST27 Brussels | €5.2m | €1.2m |
| DOCTEURS KOCH - PIENS , OPHTALMOLOGIE Woluwe-Saint-Lambert | €4.6m | €1.1m |
| DR. M. WIRIX , OPHTALMOLOGIE Hasselt | €4.6m | €1.3m |
| Dr. W. Peeters Brasschaat | €6.5m | €1.3m |
| DR. PETER BOLLARS Hasselt | €3.8m | €1.1m |
| Dr. Guy Missotten Hasselt | €4.8m | €0.8m |
| DRS. ZEYEN-COSEMANS Schoten | €3.4m | €1.4m |
Key facts about ST27
- What is the company number of ST27?
- The company number of ST27 is 0811.981.555. The VAT number is the same number with BE in front: BE 0811.981.555.
- Where is ST27 based?
- The registered office is at Louizalaan 231, 1050 Brussels.Company details
- What does ST27 do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of ST27?
- ST27 is a private limited company (BV).
- When was ST27 founded?
- ST27 was founded on 29-05-2009.
- Is ST27 still active?
- Yes, ST27 is an active enterprise in the KBO register.
- How many employees does ST27 have?
- ST27 had an average of 2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of ST27?
- The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €1.2m and 64 comparable companies (NACE 86). It probably lies between €990,000 and €1.6m.
- Is ST27 profitable?
- In financial year 2025, ST27 made a profit of €559,552.
- Where can I find the annual accounts of ST27?
- ST27 filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of ST27 due?
- ST27 must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.